Not Found

Find information on animal health topics, written for the veterinary professional.

Overview of Nonhuman Primates

By Terri Parrott, DVM, St. Charles Veterinary Hospital

This overview presents a working knowledge of the common families of nonhuman primates maintained in captivity. More species than ever are now promulgated and maintained in captivity, and many are kept in private facilities. Prosimians such as Lemur catta (ring-tailed lemur) and New World monkeys such as Cebus albifrons (white-fronted capuchin) are commonly encountered in practice. The nonhuman primate species most widely used in research are the macaques, Macaca mulatta (rhesus monkey), M fascicularis (cynomolgus monkey), and M nemestrina (pig-tailed monkey); some African species, primarily Chlorocebus aethiops (African green monkey, vervet) and Papio spp (baboons); and some of South American origin, Saimiri sciureus (squirrel monkey) and Aotus trivirgatus (owl monkey). Saguinus spp (marmosets) and Callithrix spp (tamarins, marmosets), also of South American origin, have had more limited use in research but are common in the pet trade.

Increased restrictions on exportation or reduced availability of nonhuman primates from countries of origin have led to decreased importation. Importation of nonhuman primates into the USA is prohibited except for scientific, educational, and exhibition purposes.

Nonhuman primates are natural hosts for a variety of infectious agents, many of which are zoonoses, and are also susceptible to many human infectious diseases, such as measles and tuberculosis. Consequently, newly acquired nonhuman primates should be quarantined for 1–3 mo before research use or introduction into established colonies, to permit adequate evaluation of their health status and to allow adaptation to the laboratory environment. The basic principle of quarantine is to completely isolate each group of animals and not mix animals from different shipments or sources without restarting the quarantine period. Nonhuman primates imported into the USA must undergo a 31-day minimum primary import quarantine in a facility registered with the CDC. Imported animals that die or become severely ill and require euthanasia during this quarantine period must be necropsied and the deaths reported to the CDC, Division of Quarantine. In clinical practice, any new nonhuman primate should be tested for tuberculosis, and a routine fecal examination and trichrome stain should be done. Depending on the species, routine tests such as those for cytomegalovirus, herpes simiae, and herpes simplex (1, 2, etc) also can be run at this time. Many of the nonhuman primates seen in clinical practice are infants and are immunocompromised; they are highly susceptible to common cold and influenza viruses as well as streptococcal infections and should be isolated from people with upper respiratory signs.

For nonhuman primate therapeutics, see Table: Nonhuman Primate Therapeutics a.

Nonhuman Primate Therapeutics a



11 mg/kg/day, IM or SC; 11 mg/kg, PO, bid; 62.5 mg, PO, bid (lemurs)


25–50 mg/kg, PO, bid for 10 days (gastroenteritis and inflammatory bowel disease)


40 mg/kg, PO, once, then 20 mg/kg/day, PO, for 5 days


25 mg/kg, IM or IV, bid for 10 days


50–100 mg/kg, IM or IV, bid


2.5 mg/kg, PO, bid for one day, then 2.5 mg/kg/day, PO


2–15 mg/kg/day, PO


5 mg/kg, IM or PO, once to twice daily for 10 days


30–50 mg/kg, IM or PO, bid-tid


3–5 mg/kg, IM or IV, bid for 5-7 days

Penicillin G potassium + penicillin G benzathine

20,000–60,000 U/kg, IM, once to twice daily (higher dosage in lemurs)


15–50 mg/kg, PO or IM, bid; sulfamethoxazole at 20 mg/kg, PO, bid (higher dosages for lemurs)



50 mg/kg/day, PO, for 5 days, repeated in 2 wk


200–300 mcg/kg, SC, IM, or PO, repeated in 14 days


22 mg/kg/day, PO, for 3 days, repeated in 14 days (for Giardia sp)


30–50 mg/kg, PO, bid for 5–10 days


5 mg/kg, IM, PO, or SC, once (15–20 mg/kg, PO or IM, for some cestodes; 40 mg/kg, PO or IM, for trematodes)


100 mg/kg, PO, once, repeated in 14 days (owl monkeys); 50 mg/kg/day, PO, for 2 days (Strongyloides); 75–100 mg/kg/day, PO, for 10 days (Entamoeba, Balantidium) in great apes

Anesthetics and Analgesics

Ketamine hydrochloride

10–15 mg/kg, IM, for restraint only; ketamine (15 mg/kg) with diazepam (1 mg/kg), IM, or ketamine (8 mg/kg) with midazolam (0.2–1 mg/kg), IM, for additional muscle relaxation


2 mg/kg/day, IV or IM

Inhalant gas (isoflurane, halothane)

1%–2%; maintenance of surgical plane of anesthesia

Flunixin meglumine (analgesic)

0.5– 2 mg/kg, IV, IM, or SC, bid


0.005–0.01 mg/kg, SC, IM, or IV, bid-qid (great apes)

0.015–0.02 mg/kg, IM, SC, tid-qid (New World primates)

Butorphanol tartrate

0.02 mg/kg, SC, qid (New World primates); 0.02 mg/kg (not to exceed 0.3 mg total), IM (chimpanzees); may cause profound respiratory depression


40 mcg/kg, IM, for anesthesia in combination with ketamine at 20–30 mcg/kg, IM (lemurs) or at 2–6 mg/kg, IM (macaques and baboons)


0.05–0.1 mg/kg, IV (slow) or IM: 0.1–0.5 mg/kg, IM (with ketamine helps prevent seizures in lemurs); 5 mg/animal, IM (chimpanzees)

Oxymorphone (opioid analgesic)

0.025–0.075 mg/kg, IM or IV, every 4–6 hr (New World primates); 0.15 mg/kg, SC, IM, or IV, every 4–6 hr (Old World primates); 1–1.5 mg/animal, SC or IM, every 4 hr (chimpanzees)


2.5–5 mg/kg, IV bolus induction, 0.3–0.4 mg/kg/min constant-rate infusion (baboons and macaques); 7–8 mg/kg, IV bolus (marmosets, larger nonhuman primates); 1–2 mg/kg, IV bolus (chimpanzees), followed by infusion to effect; oxygen support always available


3–5 mg/kg, IM, for restraint only (great apes), severe ataxia noted during recovery: 1–2.5 mg/kg, IM (New World primates); 1.5–3 mg/kg, IM (macaques)

a All are extra-label uses.

Resources In This Article